Perspectives on prostate cancer: advances and pending challenges for a multidisciplinary oncological approach in South America
- PMID: 37698709
- PMCID: PMC10776746
- DOI: 10.1007/s11255-023-03753-4
Perspectives on prostate cancer: advances and pending challenges for a multidisciplinary oncological approach in South America
Abstract
Prostate cancer is one of the tumors with the highest incidence and mortality among men worldwide, and this situation is no different in South America. However, epidemiological data are highly variable for each country and even more so than in North America. These data may be influenced by the very low rate of early detection of disease, availability of diagnostic methods, proper data collection, and limited access to specialized multidisciplinary treatment. For many South American countries, academic referral centers can only offer state-of-the-art diagnostics and multidisciplinary cancer treatment for patients who live in or can travel to large cities, so most patients are cared for by non-expert urologists with limited resources, which can have a negative impact on their prognosis and worsen oncologic outcomes. We aimed to show the clinical management of prostate cancer patients, the current advances in management, limitations present in South America, and how a multidisciplinary approach in referral cancer centers conformed of specialized urologists, medical oncologists, and mental health professionals can maximize patient outcomes.
Keywords: Multidisciplinary treatment; Oncology outcomes; Prostate cancer; Referral centers; South American.
© 2023. The Author(s).
Conflict of interest statement
No conflict of interest.
References
-
- European Association of Urology [Internet]. 2022 [cited 2022 Sep 22]. EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022. Available from: https://uroweb.org/guidelines/prostate-cancer. Accessed 15 June 2023
-
- Hurwitz LM, Cullen J, Elsamanoudi S, Kim DJ, Hudak J, Colston M, et al. A prospective cohort study of treatment decision-making for prostate cancer following participation in a multidisciplinary clinic. Urol Oncol: Semin Orig Investig. 2016;34(5):233.e17–233.e25. doi: 10.1016/j.urolonc.2015.11.014. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
